Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Alnylam Pharmaceuticals, Inc. company logo
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY)

Profile

Company profile for Alnylam Pharmaceuticals, Inc. (ALNY)
MetricValue
Full NameAlnylam Pharmaceuticals, Inc.
TickerNASDAQ: ALNY
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
Indexes
Websitealnylam.com
Employees2,230

Key Metrics

Alnylam Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$400.17
Price, 1D Change+0.63%
Market Cap$53B
-
PE Ratio1,663.91
Beta0.90
Revenue$2B
Revenue, 1Y Change+22.97%
EPS-$2.18
EPS, 1Y Change+38.18%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Alnylam Pharmaceuticals, Inc. chart

Events

Alnylam Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

ALNY Estimates
MetricDateValue
EPS-$2.18
EPS Estimate$4.96
EPS Est. Change+327.43%
Revenue$2.25B
Revenue Estimate$3.75B
Revenue Est. Change+66.74%
Current Price$400.17
Price Target-$500.00
Price Tgt. Change-+24.95%

🔒 Log In To Unlock Full Data

EPS

ALNY EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$3.47-$3.52-1.57%
-$0.18-$2.18-1,118.68%
$4.96N/A+327.43%
$11.18N/A+613.18%
ALNY EPS reported versus estimate values chart

Revenue

ALNY revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$1.83B$1.83B-0.02%
$2.24B$2.25B+0.57%
$3.75BN/A+66.74%
$5.46BN/A+142.87%
ALNY revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

ALNY Performance
MetricDateValue
Price, 1Y+71.29%
Price, 3Y+68.39%
Market Cap, 1Y+75.03%
Market Cap, 3Y+79.51%
Revenue, 1Y+22.97%
Revenue, 3Y+166.29%
EPS, 1Y+38.18%
EPS, 3Y+69.74%

🔒 Log In To Unlock Full Data

Technical Indicators

ALNY Technical Indicators
MetricDateValue
Current Price$400.17
SMA 200$371.91
SMA 200 vs Price-7.06%
SMA 50$434.67
SMA 50 vs Price+8.62%
Beta0.90
ATR$12.36
14-Day RSI39.84
10-Day Volatility17.60%
1-Year Volatility43.52%

Dividends

ALNY Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

ALNY Income & Profitability
MetricDateValue
Revenue$2.25B
EPS-$2.18
Gross Profit$1.92B
Gross Margin85.62%
Operating Profit-$176.89M
Operating Margin-7.87%
Net Income-$278.16M
Net Margin-12.37%
EBITDA-$178.85M

🔒 Log In To Unlock Full Data

Financial Health

ALNY Financial Health
MetricDateValue
Debt To Equity40.89
Current Ratio2.78
Quick Ratio2.71
-
F-Score6
Altman Z-Score6.05

Valuations

ALNY Valuations
MetricDateValue
PE Ratio1,663.91
PS Ratio16.47
PB Ratio226.03
EV/EBITDA164.84
Enterprise ValueN/A-

Balance Sheet

ALNY Balance Sheet
MetricDateValue
Book Value$67.09M
Cash & Equivalents$966.43M
Total Assets$4.30B
Current Assets$3.30B
Total Liabilities$4.23B
Current Liabilities$1.19B
Total Debt$2.74B
Short Term Debt$154.90M
Accounts Payable$88.42M

Expenses

ALNY Expenses
MetricDateValue
Total Expenses$2.43B
Operating Expenses$2.10B
Cost Of Goods Sold$323.37M
SG&A$975.53M
D&A$56.67M
Interest Expense$0.00
Income Tax-$99.22M

Cash Flow

ALNY Cash Flow
MetricDateValue
CFO-$8.31M
CFI-$116.84M
CFF$294.16M
Capex$34.28M
Free Cash Flow-$42.59M

Recent analyst updates

ALNY Recent analyst updates
MetricDateValue
Leerink Partners→
Stifel→
Wells Fargo→
Piper Sandler→
Barclays→
Jefferies→
Truist Securities→
JP Morgan→
HC Wainwright & Co.→
Stifel→

Analyst sentiment

Sentiment over the past month
ALNY analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
ALNY institutional ownership distribution chart

Screeners with ALNY

Data Sources & References

  1. ALNY Official Website www.alnylam.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1178670/000119312525230201/0001193125-25-230201-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178670/000117867025000026/0001178670-25-000026-index.htm
  4. List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
  5. ALNY Profile on Yahoo Finance finance.yahoo.com/quote/ALNY
  6. ALNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alny

FAQ

  • What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?

    The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY

  • Does Alnylam Pharmaceuticals, Inc. pay dividends?

    No, Alnylam Pharmaceuticals, Inc. does not pay dividends

  • What sector is Alnylam Pharmaceuticals, Inc. in?

    Alnylam Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Alnylam Pharmaceuticals, Inc. in?

    Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry

  • What country is Alnylam Pharmaceuticals, Inc. based in?

    Alnylam Pharmaceuticals, Inc. is headquartered in United States

  • When did Alnylam Pharmaceuticals, Inc. go public?

    Alnylam Pharmaceuticals, Inc. initial public offering (IPO) was on June 1, 2004

  • Is Alnylam Pharmaceuticals, Inc. in the S&P 500?

    No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?

    Yes, Alnylam Pharmaceuticals, Inc. is included in the NASDAQ 100 index

  • Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?

    No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Alnylam Pharmaceuticals, Inc. last earnings report?

    Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on October 30, 2025

  • When does Alnylam Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Alnylam Pharmaceuticals, Inc. is February 12, 2026